NYSE - Nasdaq Real Time Price USD

Enovis Corporation (ENOV)

Compare
38.74 -0.03 (-0.06%)
As of 3:52 PM EDT. Market Open.
Loading Chart for ENOV
DELL
  • Previous Close 38.77
  • Open 38.52
  • Bid 38.54 x 800
  • Ask 38.56 x 4000
  • Day's Range 38.39 - 38.93
  • 52 Week Range 38.27 - 65.03
  • Volume 483,849
  • Avg. Volume 653,843
  • Market Cap (intraday) 2.164B
  • Beta (5Y Monthly) 2.01
  • PE Ratio (TTM) --
  • EPS (TTM) -1.95
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 68.00

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

www.enovis.com

6,550

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ENOV

View More

Performance Overview: ENOV

Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ENOV
30.84%
S&P 500
21.15%

1-Year Return

ENOV
21.51%
S&P 500
33.28%

3-Year Return

ENOV
53.56%
S&P 500
31.59%

5-Year Return

ENOV
15.88%
S&P 500
97.94%

Compare To: ENOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENOV

View More

Valuation Measures

Annual
As of 10/9/2024
  • Market Cap

    2.17B

  • Enterprise Value

    3.55B

  • Trailing P/E

    --

  • Forward P/E

    12.76

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    0.66

  • Enterprise Value/Revenue

    1.85

  • Enterprise Value/EBITDA

    20.41

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.73%

  • Return on Assets (ttm)

    -0.10%

  • Return on Equity (ttm)

    -3.16%

  • Revenue (ttm)

    1.91B

  • Net Income Avi to Common (ttm)

    -107.11M

  • Diluted EPS (ttm)

    -1.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35M

  • Total Debt/Equity (mrq)

    43.09%

  • Levered Free Cash Flow (ttm)

    -26.55M

Research Analysis: ENOV

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 525.16M
Earnings -18.64M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

58.00
68.00 Average
38.74 Current
75.00 High
 

Company Insights: ENOV

Research Reports: ENOV

View More
  • Lowering target price to $34.00

    ENOVIS CORP has an Investment Rating of SELL; a target price of $34.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Lowering target price to $35.00

    ENOVIS CORP has an Investment Rating of SELL; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Raising target price to $36.00

    ENOVIS CORP has an Investment Rating of SELL; a target price of $36.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Lowering target price to $35.00

    ENOVIS CORP has an Investment Rating of SELL; a target price of $35.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch